688029 南微医学
已收盘 10-10 15:00:00
资讯
新帖
简况
股市必读：9月30日南微医学发生2笔大宗交易 成交金额1505.26万元
证券之星 · 10-08 17:40
股市必读：9月30日南微医学发生2笔大宗交易 成交金额1505.26万元
南微医学涨7.52%，国金证券一个月前给出“买入”评级
证券之星 · 09-30
南微医学涨7.52%，国金证券一个月前给出“买入”评级
南微医学（688029）披露2025年半年度权益分派实施后调整回购价格上限，9月29日股价下跌0.99%
证券之星 · 09-29
南微医学（688029）披露2025年半年度权益分派实施后调整回购价格上限，9月29日股价下跌0.99%
每周股票复盘：XD南微医（688029）南微医学拟每股派0.5元现金红利
证券之星 · 09-27
每周股票复盘：XD南微医（688029）南微医学拟每股派0.5元现金红利
南微医学（688029）披露2025年半年度权益分派实施公告，9月22日股价上涨0.37%
证券之星 · 09-22
南微医学（688029）披露2025年半年度权益分派实施公告，9月22日股价上涨0.37%
中国银河：给予南微医学买入评级，目标价134.67元
证券之星 · 09-07
中国银河：给予南微医学买入评级，目标价134.67元
每周股票复盘：南微医学（688029）回购进展、业绩说明会及分红调整
证券之星 · 09-06
每周股票复盘：南微医学（688029）回购进展、业绩说明会及分红调整
南微医学股价上涨3.76% 医疗器械板块活跃度提升
市场资讯 · 09-05
南微医学股价上涨3.76% 医疗器械板块活跃度提升
南微医学：9月11日将召开2025年半年度业绩说明会
证券日报网 · 09-03
南微医学：9月11日将召开2025年半年度业绩说明会
每周股票复盘：南微医学（688029）股东减持及半年度分红方案
证券之星 · 08-23
每周股票复盘：南微医学（688029）股东减持及半年度分红方案
南微医学股价下跌1.95% 社保基金二季度持股比例达4.89%
金融界 · 08-21
南微医学股价下跌1.95% 社保基金二季度持股比例达4.89%
南微医学最新公告：中科招商拟减持不超过2%公司股份
证券之星 · 08-17
南微医学最新公告：中科招商拟减持不超过2%公司股份
本周机构调研集中度有所提升 4家公司接受百家以上机构调研
格隆汇 · 08-17
本周机构调研集中度有所提升 4家公司接受百家以上机构调研
【机构调研记录】湘财基金调研南微医学
证券之星 · 08-14
【机构调研记录】湘财基金调研南微医学
【机构调研记录】红塔红土调研南微医学
证券之星 · 08-14
【机构调研记录】红塔红土调研南微医学
【机构调研记录】广发基金调研博杰股份、南微医学
证券之星 · 08-14
【机构调研记录】广发基金调研博杰股份、南微医学
【机构调研记录】富安达基金调研帝尔激光、南微医学等3只个股（附名单）
证券之星 · 08-14
【机构调研记录】富安达基金调研帝尔激光、南微医学等3只个股（附名单）
【机构调研记录】信达澳亚基金调研佰维存储、南微医学
证券之星 · 08-14
【机构调研记录】信达澳亚基金调研佰维存储、南微医学
社保基金最新持仓披露：银行股依旧“心头好” 还有哪些独门重仓股？
智通财经 · 08-13
社保基金最新持仓披露：银行股依旧“心头好” 还有哪些独门重仓股？
医疗器械板块拉升，赛诺医疗涨超14%
E公司 · 08-12
医疗器械板块拉升，赛诺医疗涨超14%
加载更多
公司概况
公司名称：
南微医学科技股份有限公司
所属行业：
专用设备制造业
上市日期：
2019-07-22
主营业务：
南微医学科技股份有限公司的主营业务是微创医疗器械的研发、制造和销售。公司的主要产品是内镜诊疗器械、微波/射频消融设备及耗材、一次性内镜。
发行价格：
52.45
{"stockData":{"symbol":"688029","market":"SH","secType":"STK","nameCN":"南微医学","latestPrice":97.78,"timestamp":1760079600000,"preClose":98.21,"halted":0,"volume":3479842,"delay":0,"changeRate":-0.0044,"floatShares":188000000,"shares":188000000,"eps":3.2268,"marketStatus":"已收盘","change":-0.43,"latestTime":"10-10 15:00:00","open":97.53,"high":98.2,"low":95.4,"amount":338000000,"amplitude":0.0285,"askPrice":97.78,"askSize":18,"bidPrice":97.67,"bidSize":4,"shortable":0,"etf":0,"ttmEps":3.2268,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1760319000000},"marketStatusCode":5,"adr":0,"adjPreClose":98.21,"symbolType":"stock_kcb","openAndCloseTimeList":[[1760059800000,1760067000000],[1760072400000,1760079600000]],"highLimit":108.03,"lowLimit":88.39,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":187847422,"isCdr":false,"pbRate":4.56,"roa":"--","peRate":30.302467,"roe":"9.11%","epsLYR":2.95,"committee":0.323077,"marketValue":18368000000,"turnoverRate":0.0185,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2025-10-13。","afterMarket":{"amount":0,"volume":0,"close":97.78,"buyVolume":0,"sellVolume":0,"time":1760081637768,"indexStatus":"已收盘 10-10 15:30:00","preClose":98.21},"floatMarketCap":18368000000},"requestUrl":"/m/hq/s/688029","defaultTab":"news","newsList":[{"id":"2574697508","title":"股市必读：9月30日南微医学发生2笔大宗交易 成交金额1505.26万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2574697508","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574697508?lang=zh_cn&edition=full","pubTime":"2025-10-09 01:40","pubTimestamp":1759945219,"startTime":"0","endTime":"0","summary":"截至2025年9月30日收盘，南微医学报收于100.35元，上涨7.52%，换手率2.24%，成交量4.21万手，成交额4.14亿元。来自公司公告汇总：因实施2025年半年度权益分派，南微医学回购价格上限由95.54元/股调整至95.04元/股，自9月26日起生效。交易信息汇总资金流向9月30日主力资金净流入2454.65万元，占总成交额5.93%；游资资金净流入346.88万元，占总成交额0.84%；散户资金净流出2801.53万元，占总成交额6.76%。大宗交易9月30日南微医学发生2笔大宗交易，成交金额1505.26万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025100900000512.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688029"],"gpt_icon":0},{"id":"2571314072","title":"南微医学涨7.52%，国金证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2571314072","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571314072?lang=zh_cn&edition=full","pubTime":"2025-09-30 16:21","pubTimestamp":1759220512,"startTime":"0","endTime":"0","summary":"今日南微医学涨7.52%，收盘报100.35元。2025年8月12日，国金证券研究员甘坛焕,何冠洲发布了对南微医学的研报《推进国际化战略，中报海外持续高增长》，该研报对南微医学给出“买入”评级。研报中预计2025-2027年公司归母净利润分别为6.75、8.25、10.12亿元，同比+22%、+22%、+23%，现价对应PE为26、21、17倍，维持“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为中金公司的冯喜鹏。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025093000025885.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029"],"gpt_icon":0},{"id":"2571337577","title":"南微医学（688029）披露2025年半年度权益分派实施后调整回购价格上限，9月29日股价下跌0.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2571337577","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571337577?lang=zh_cn&edition=full","pubTime":"2025-09-29 22:35","pubTimestamp":1759156523,"startTime":"0","endTime":"0","summary":"截至2025年9月29日收盘，南微医学报收于93.33元，较前一交易日下跌0.99%，最新总市值为175.32亿元。近日，南微医学科技股份有限公司发布关于2025年半年度权益分派实施后调整回购价格上限的公告。根据公告内容，因实施2025年半年度权益分派，向全体股东每10股派发现金红利5.00元（含税），公司对回购股份的价格上限进行相应调整。公司表示，除上述调整外，本次回购股份方案的其他事项均不发生变化。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092900035590.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029","BK0251"],"gpt_icon":0},{"id":"2570826891","title":"每周股票复盘：XD南微医（688029）南微医学拟每股派0.5元现金红利","url":"https://stock-news.laohu8.com/highlight/detail?id=2570826891","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570826891?lang=zh_cn&edition=full","pubTime":"2025-09-28 02:39","pubTimestamp":1758998351,"startTime":"0","endTime":"0","summary":"截至2025年9月26日收盘，XD南微医报收于94.26元，较上周的91.27元上涨3.28%。本周，XD南微医9月25日盘中最高价报98.8元。本周关注点公司公告汇总：南微医学2025年半年度权益分派方案确定，每10股派发现金红利5.00元（含税）。截至公告日，公司总股本187,847,422股，扣除回购股份1,016,119股，实际参与分配股本186,831,303股，合计派发现金红利93,415,651.50元（含税）。差异化分红导致每股现金红利按总股本摊薄后约为0.4973元/股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092800000625.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029","BK0251"],"gpt_icon":0},{"id":"2569920072","title":"南微医学（688029）披露2025年半年度权益分派实施公告，9月22日股价上涨0.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2569920072","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569920072?lang=zh_cn&edition=full","pubTime":"2025-09-22 17:21","pubTimestamp":1758532914,"startTime":"0","endTime":"0","summary":"截至2025年9月22日收盘，南微医学报收于91.61元，较前一交易日上涨0.37%，最新总市值为172.09亿元。公司于近日发布《2025年半年度权益分派实施公告》。股权登记日为2025年9月25日，除权（息）日及现金红利发放日均为2025年9月26日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092200022899.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029","BK0251"],"gpt_icon":0},{"id":"2565528637","title":"中国银河：给予南微医学买入评级，目标价134.67元","url":"https://stock-news.laohu8.com/highlight/detail?id=2565528637","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565528637?lang=zh_cn&edition=full","pubTime":"2025-09-07 17:45","pubTimestamp":1757238325,"startTime":"0","endTime":"0","summary":"中国银河证券股份有限公司程培,孟熙近期对南微医学进行研究并发布了研究报告《南微医学深度报告：内镜耗材龙头全球化提速，创新驱动二次成长》，给予南微医学买入评级，目标价134.67元。南微医学是技术实力过硬、产品系列丰富的国产微创器械领军企业，聚焦微创诊疗全链条，打造精准介入解决方案。微创器械代际跃迁之际，以南微医学为代表的国产品牌实现弯道超车，形成差异化竞争优势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090700009040.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601881","688029"],"gpt_icon":0},{"id":"2565651009","title":"每周股票复盘：南微医学（688029）回购进展、业绩说明会及分红调整","url":"https://stock-news.laohu8.com/highlight/detail?id=2565651009","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565651009?lang=zh_cn&edition=full","pubTime":"2025-09-07 03:11","pubTimestamp":1757185871,"startTime":"0","endTime":"0","summary":"截至2025年9月5日收盘，南微医学报收于90.7元，较上周的91.4元下跌0.77%。本周，南微医学9月1日盘中最高价报93.93元。调整原因为公司回购专用证券账户中股份总数发生变动，实际参与本次利润分配的股份总数为186,831,303股。公司总股本为187,847,422股，回购专用证券账户中的股份数为1,016,119股，不参与利润分配。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090700000581.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029","BK0251"],"gpt_icon":0},{"id":"2565156921","title":"南微医学股价上涨3.76% 医疗器械板块活跃度提升","url":"https://stock-news.laohu8.com/highlight/detail?id=2565156921","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565156921?lang=zh_cn&edition=full","pubTime":"2025-09-05 22:35","pubTimestamp":1757082945,"startTime":"0","endTime":"0","summary":"南微医学最新股价报90.70元，较前一交易日上涨3.29元。该股开盘价为87.40元，盘中最高触及90.89元，最低下探至87.40元，全天成交2.39亿元，换手率达到1.42%。南微医学主营业务为微创医疗器械的研发、生产和销售，产品涵盖内镜诊疗、肿瘤消融等领域。从资金流向来看，南微医学当日主力资金净流入1327.03万元，占流通市值的0.08%。但近五个交易日整体呈现资金净流出状态，累计净流出7391.88万元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/09/05223552962492.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["688029","BK1222","09996","BK1583","159883","BK0251","09997","BK1574","BK1100"],"gpt_icon":0},{"id":"2564986803","title":"南微医学：9月11日将召开2025年半年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2564986803","media":"证券日报网","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564986803?lang=zh_cn&edition=full","pubTime":"2025-09-03 18:39","pubTimestamp":1756895940,"startTime":"0","endTime":"0","summary":"证券日报网讯9月3日晚间，南微医学发布公告称，公司2025年半年度业绩说明会定于2025年9月11日上午9：00—10：00召开。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-09-03/doc-infpfnyf2609134.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-09-03/doc-infpfnyf2609134.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0251","688029"],"gpt_icon":0},{"id":"2561404253","title":"每周股票复盘：南微医学（688029）股东减持及半年度分红方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2561404253","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561404253?lang=zh_cn&edition=full","pubTime":"2025-08-24 06:20","pubTimestamp":1755987628,"startTime":"0","endTime":"0","summary":"截至2025年8月22日收盘，南微医学报收于92.85元，较上周的97.91元下跌5.17%。本周，南微医学8月18日盘中最高价报98.9元。深圳市中科招商创业投资有限公司持有南微医学科技股份有限公司股份41752818股，占公司总股本的22.2270%。南微医学科技股份有限公司2025年第二次临时股东大会会议资料。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082400001852.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688029"],"gpt_icon":0},{"id":"2561925364","title":"南微医学股价下跌1.95% 社保基金二季度持股比例达4.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561925364","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561925364?lang=zh_cn&edition=full","pubTime":"2025-08-22 00:02","pubTimestamp":1755792179,"startTime":"0","endTime":"0","summary":"南微医学股价报93.12元，较前一交易日下跌1.85元。开盘价为94.20元，最高触及95.87元，最低下探至92.28元，成交量为42811手，成交金额4.01亿元。南微医学属于医疗器械行业，主要从事微创医疗器械的研发、生产和销售。数据显示，2025年二季度末，3家社保基金组合合计持有南微医学917.85万股，占流通股比例为4.89%，持股市值达6.20亿元。2025年8月21日，南微医学主力资金净流入1158万元，近五日主力资金累计净流入4892.8万元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/22000252598582.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0251","688029"],"gpt_icon":0},{"id":"2560921005","title":"南微医学最新公告：中科招商拟减持不超过2%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2560921005","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560921005?lang=zh_cn&edition=full","pubTime":"2025-08-17 16:09","pubTimestamp":1755418182,"startTime":"0","endTime":"0","summary":"南微医学(688029.SH)公告称，公司股东中科招商因自身资金需求，拟通过上海证券交易所交易系统以集中竞价、大宗交易方式减持公司股份合计不超过3,756,948股，不超过公司总股本的2%。其中，通过集中竞价交易方式减持不超过1,878,474股，通过大宗交易方式减持不超过1,878,474股。减持期间为2025年9月9日至2025年12月7日。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081700005306.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029","BK0251"],"gpt_icon":0},{"id":"2560926089","title":"本周机构调研集中度有所提升 4家公司接受百家以上机构调研","url":"https://stock-news.laohu8.com/highlight/detail?id=2560926089","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560926089?lang=zh_cn&edition=full","pubTime":"2025-08-17 08:15","pubTimestamp":1755389727,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0211977185.USD","BK0251","LU0307460666.USD","002536","688029","605588","BK0186","301616","BK0214","BK0231","BK0276","688291","BK0264","300850","002939","LU0588546209.SGD","BK0259","688581"],"gpt_icon":0},{"id":"2559987762","title":"【机构调研记录】湘财基金调研南微医学","url":"https://stock-news.laohu8.com/highlight/detail?id=2559987762","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559987762?lang=zh_cn&edition=full","pubTime":"2025-08-14 08:04","pubTimestamp":1755129885,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及8月13日披露的机构调研信息，湘财基金近期对1家上市公司进行了调研，相关名单如下：1）南微医学 调研纪要：南微医学海外团队超400人，主要分布在欧美市场，聚焦主业消化内镜领域，积极寻找收并购标的。湘财基金成立于2018年，截至目前，资产管理规模71.35亿元，排名151/210；资产管理规模71.33亿元，排名131/210；管理公募基金数37只，排名115/210；旗下公募基金经理8人，排名119/210。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081400005393.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029","BK0251"],"gpt_icon":0},{"id":"2559987082","title":"【机构调研记录】红塔红土调研南微医学","url":"https://stock-news.laohu8.com/highlight/detail?id=2559987082","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559987082?lang=zh_cn&edition=full","pubTime":"2025-08-14 08:04","pubTimestamp":1755129884,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及8月13日披露的机构调研信息，红塔红土近期对1家上市公司进行了调研，相关名单如下：1）南微医学 调研纪要：南微医学海外团队超400人，主要分布在欧美市场，聚焦主业消化内镜领域，积极寻找收并购标的。旗下最近一年表现最佳的公募基金产品为红塔红土信息产业精选股票发起式A，最新单位净值为1.68，近一年增长67.11%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081400005391.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029","BK0251"],"gpt_icon":0},{"id":"2559498774","title":"【机构调研记录】广发基金调研博杰股份、南微医学","url":"https://stock-news.laohu8.com/highlight/detail?id=2559498774","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559498774?lang=zh_cn&edition=full","pubTime":"2025-08-14 08:04","pubTimestamp":1755129870,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及8月13日披露的机构调研信息，广发基金近期对2家上市公司进行了调研，相关名单如下：1）博杰股份 调研纪要：博杰股份在2023年的业务结构有所调整，消费电子设备业务占比下降，I服务器和汽车电子业务占比提升。2）南微医学 调研纪要：南微医学海外团队超400人，主要分布在欧美市场，聚焦主业消化内镜领域，积极寻找收并购标的。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081400005370.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","002975","688029"],"gpt_icon":0},{"id":"2559987038","title":"【机构调研记录】富安达基金调研帝尔激光、南微医学等3只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2559987038","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559987038?lang=zh_cn&edition=full","pubTime":"2025-08-14 08:04","pubTimestamp":1755129869,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及8月13日披露的机构调研信息，富安达基金近期对3家上市公司进行了调研，相关名单如下：1）帝尔激光 调研纪要：2025年上半年，帝尔激光面对光伏行业产能过剩压力，坚持创新，实现营业收入11.70亿元，同比增长29.20%，净利润3.27亿元，同比增长38.37%。2）南微医学 调研纪要：南微医学海外团队超400人，主要分布在欧美市场，聚焦主业消化内镜领域，积极寻找收并购标的。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081400005367.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688029","300776","BK0251"],"gpt_icon":0},{"id":"2559793987","title":"【机构调研记录】信达澳亚基金调研佰维存储、南微医学","url":"https://stock-news.laohu8.com/highlight/detail?id=2559793987","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559793987?lang=zh_cn&edition=full","pubTime":"2025-08-14 08:03","pubTimestamp":1755129832,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及8月13日披露的机构调研信息，信达澳亚基金近期对2家上市公司进行了调研，相关名单如下：1）佰维存储 调研纪要：佰维存储在2025年上半年业务取得多项突破，包括手机、PC、智能穿戴、企业级和智能汽车领域。2）南微医学 调研纪要：南微医学海外团队超400人，主要分布在欧美市场，聚焦主业消化内镜领域，积极寻找收并购标的。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081400005328.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688525","BK0214","688029"],"gpt_icon":0},{"id":"2559670781","title":"社保基金最新持仓披露：银行股依旧“心头好” 还有哪些独门重仓股？","url":"https://stock-news.laohu8.com/highlight/detail?id=2559670781","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559670781?lang=zh_cn&edition=full","pubTime":"2025-08-13 16:21","pubTimestamp":1755073277,"startTime":"0","endTime":"0","summary":"重新加仓的期间，常熟银行股价小幅上涨。截至今年上半年底，2只社保基金组合对海大集团的合计持股数达到2103.44万股，较一季度末持股数近乎翻倍。自从社保基金413组合新进前十大股东行列后，今年二季度首次对艾德生物减持，截至季末持股数为512.15万股。不同的是，这2只个股并非个别社保基金的独门重仓股，而是被至少2只社保基金组合持有。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1329020.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0072462343.USD","001258","IE00B5MMRT66.SGD","603129","002648","BK0039","LU1023057109.AUD","BK0051","BK0271","BK0005","LU1328615791.USD","601128","BK0185","BK0201","IE00B543WZ88.USD","LU1048588211.SGD","BK0175","300416","600885","BK0279","002064","LU2460026573.USD","SGXZ81163826.USD","BK0028","BK0176","LU0359201612.USD","300685","688029","BK0077","BK0070","LU0588546209.SGD","000059","BK0278","300850","BK0169","BK0196","IE0008368742.USD","BK0186","IE00BZ08YS42.EUR","IE00BPRC5H50.USD","LU1831875114.USD","LU0211977185.USD","BK0042","002353","BK0118","BK0224","LU0359201885.HKD","LU0307460666.USD","IE00B031HY20.USD","300627"],"gpt_icon":0},{"id":"2558148692","title":"医疗器械板块拉升，赛诺医疗涨超14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558148692","media":"E公司","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558148692?lang=zh_cn&edition=full","pubTime":"2025-08-12 09:54","pubTimestamp":1754963662,"startTime":"0","endTime":"0","summary":"人民财讯8月12日电，医疗器械板块拉升，赛诺医疗涨超14%，迈普医学、南微医学涨超6%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812095422a6e094f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812095422a6e094f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159883","688029","BK0251","688108"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1760137689905,"stockEarnings":[{"period":"1week","weight":-0.0256},{"period":"1month","weight":0.0667},{"period":"3month","weight":0.4},{"period":"6month","weight":0.6625},{"period":"1year","weight":0.3708},{"period":"ytd","weight":0.4766}],"compareEarnings":[{"period":"1week","weight":0.0037},{"period":"1month","weight":0.0222},{"period":"3month","weight":0.1102},{"period":"6month","weight":0.2034},{"period":"1year","weight":0.1802},{"period":"ytd","weight":0.1627}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"南微医学科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"12345人(较上一季度减少7.27%)","perCapita":"15216股","listingDate":"2019-07-22","address":"江苏省南京市浦口区高新开发区高科三路10号","registeredCapital":"18784万元","survey":" 南微医学科技股份有限公司的主营业务是微创医疗器械的研发、制造和销售。公司的主要产品是内镜诊疗器械、微波/射频消融设备及耗材、一次性内镜。","listedPrice":52.45},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.3","shortVersion":"4.35.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"南微医学(688029)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供南微医学(688029)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"南微医学,688029,南微医学股票,南微医学股票老虎,南微医学股票老虎国际,南微医学行情,南微医学股票行情,南微医学股价,南微医学股市,南微医学股票价格,南微医学股票交易,南微医学股票购买,南微医学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"南微医学(688029)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供南微医学(688029)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}